Evaluation of Microscopic Tumour Extension in Localized Stage Non-Small-Cell Lung Cancer for Stereotactic Radiotherapy Planning.

Date publication

mars 2022

Journal

Cancers

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine , Dr LINDNER Véronique , Pr NOEL Georges

Tous les auteurs :
Schmitt M, Aussenac L, Seitlinger J, Lindner V, Noël G, Antoni D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35267589

Résumé

Stereotactic radiotherapy for localised stage non-small-cell lung carcinoma (NSCLC) is an alternative indication for patients who are inoperable or refuse surgery. A study showed that the microscopic tumour extension (ME) of NSCLC varied according to the histological type, which allowed us to deduce adapted margins for the clinical target volume (CTV). However, to date, no study has been able to define the most relevant margins for patients with stage 1 tumours.

Mots clés

adenocarcinoma, non-small-cell lung carcinoma, squamous cell carcinoma, stereotactic body radiation therapy

Référence

Cancers (Basel). 2022 Mar 2;14(5):